| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |